{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:05:01Z","timestamp":1780473901323,"version":"3.54.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>The process of drug development is inherently complex, marked by extended intervals from the inception of a pharmaceutical agent to its eventual launch in the market. Additionally, each phase in this process is associated with a significant failure rate, amplifying the inherent challenges of this task. Computational virtual screening powered by machine learning algorithms has emerged as a promising approach for predicting therapeutic efficacy. However, the complex relationships between the features learned by these algorithms can be challenging to decipher.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have engineered an artificial neural network model designed specifically for predicting drug sensitivity. This model utilizes a biologically informed visible neural network, thereby enhancing its interpretability. The trained model allows for an in-depth exploration of the biological pathways integral to prediction and the chemical attributes of drugs that impact sensitivity. Our model harnesses multiomics data derived from a different tumor tissue sources, as well as molecular descriptors that encapsulate the properties of drugs. We extended the model to predict drug synergy, resulting in favorable outcomes while retaining interpretability. Given the imbalanced nature of publicly available drug screening datasets, our model demonstrated superior performance to state-of-the-art visible machine learning algorithms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability and implementation<\/jats:title>\n                    <jats:p>MOViDA is implemented in Python using PyTorch library and freely available for download at https:\/\/github.com\/Luigi-Ferraro\/MOViDA. Training data, RIS score and drug features are archived on Zenodo https:\/\/doi.org\/10.5281\/zenodo.8180380.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btad432","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T21:03:43Z","timestamp":1689023023000},"source":"Crossref","is-referenced-by-count":14,"title":["MOViDA: multiomics visible drug activity prediction with a biologically informed neural network model"],"prefix":"10.1093","volume":"39","author":[{"given":"Luigi","family":"Ferraro","sequence":"first","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, University of Miami , Miami, FL 33131, United States"},{"name":"BIOGEM Institute of Molecular Biology and Genetics , 83031 Ariano Irpino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scala","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Naples \u201cFederico II\u201d , 80128 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-3487","authenticated-orcid":false,"given":"Luigi","family":"Cerulo","sequence":"additional","affiliation":[{"name":"BIOGEM Institute of Molecular Biology and Genetics , 83031 Ariano Irpino, Italy"},{"name":"Department of Science and Technology, University of Sannio , 82100 Benevento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Carosati","sequence":"additional","affiliation":[{"name":"Department of Chemical and Pharmaceutical Sciences, University of Trieste , 34127 Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4702-6617","authenticated-orcid":false,"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, University of Miami , Miami, FL 33131, United States"},{"name":"Department of Public Health Sciences , Miami, FL 33131, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"2023072808460591800_btad432-B1","doi-asserted-by":"crossref","first-page":"bbab393","DOI":"10.1093\/bib\/bbab393","article-title":"Representation of molecules for drug response prediction","volume":"23","author":"An","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023072808460591800_btad432-B2","first-page":"283","author":"Baccianella","year":"2009"},{"key":"2023072808460591800_btad432-B3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/bib\/bbz171","article-title":"Deep learning for drug response prediction in cancer","volume":"22","author":"Baptista","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023072808460591800_btad432-B4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"2023072808460591800_btad432-B5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/jm101421d","article-title":"A novel approach for predicting p-glycoprotein (ABCB1) inhibition using molecular interaction fields","volume":"54","author":"Broccatelli","year":"2011","journal-title":"J Med Chem"},{"key":"2023072808460591800_btad432-B6","doi-asserted-by":"crossref","first-page":"799712","DOI":"10.3389\/fphar.2021.799712","article-title":"Bioinformatics research on drug sensitivity prediction","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023072808460591800_btad432-B7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12920-018-0460-9","article-title":"Predicting drug response of tumors from integrated genomic profiles by deep neural networks","volume":"12","author":"Chiu","year":"2019","journal-title":"BMC Med Genom"},{"key":"2023072808460591800_btad432-B8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13321-019-0364-5","article-title":"Kekulescope: prediction of cancer cell line sensitivity and compound potency using convolutional neural networks trained on compound images","volume":"11","author":"Cort\u00e9s-Ciriano","year":"2019","journal-title":"J Cheminform"},{"key":"2023072808460591800_btad432-B9","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1021\/jm990968+","article-title":"Predicting blood-brain barrier permeation from three-dimensional molecular structure","volume":"43","author":"Crivori","year":"2000","journal-title":"J Med Chem"},{"key":"2023072808460591800_btad432-B10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12859-020-3442-9","article-title":"Machine learning prediction of oncology drug targets based on protein and network properties","volume":"21","author":"Dezs\u0151","year":"2020","journal-title":"BMC Bioinform"},{"key":"2023072808460591800_btad432-B11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.25.5.1608-1619.2005","article-title":"Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas","volume":"25","author":"Duan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2023072808460591800_btad432-B12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","article-title":"Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines","volume":"6","author":"Ellrott","year":"2018","journal-title":"Cell Syst"},{"key":"2023072808460591800_btad432-B13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-021-03922-4","article-title":"Biologically informed deep neural network for prostate cancer discovery","volume":"598","author":"Elmarakeby","year":"2021","journal-title":"Nature"},{"key":"2023072808460591800_btad432-B14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nchembio.1337","article-title":"Metrics other than potency reveal systematic variation in responses to cancer drugs","volume":"9","author":"Fallahi-Sichani","year":"2013","journal-title":"Nat Chem Biol"},{"key":"2023072808460591800_btad432-B15","doi-asserted-by":"crossref","first-page":"bbab408","DOI":"10.1093\/bib\/bbab408","article-title":"An overview of machine learning methods for monotherapy drug response prediction","volume":"23","author":"Firoozbakht","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023072808460591800_btad432-B16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature25171","article-title":"A metabolic function of FGFR3-TACC3 gene fusions in cancer","volume":"553","author":"Frattini","year":"2018","journal-title":"Nature"},{"key":"2023072808460591800_btad432-B17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"2023072808460591800_btad432-B18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eswa.2016.12.035","article-title":"Learning from class-imbalanced data: review of methods and applications","volume":"73","author":"Haixiang","year":"2017","journal-title":"Expert Syst Appl"},{"key":"2023072808460591800_btad432-B19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12859-018-2500-z","article-title":"PASNet: pathway-associated sparse deep neural network for prognosis prediction from high-throughput data","volume":"19","author":"Hao","year":"2018","journal-title":"BMC Bioinform"},{"key":"2023072808460591800_btad432-B20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","article-title":"Learning from imbalanced data","volume":"21","author":"He","year":"2009","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"2023072808460591800_btad432-B21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2023072808460591800_btad432-B22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"key":"2023072808460591800_btad432-B23","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.4110\/in.2018.18.e26","article-title":"Thapsigargin increases IL-2 production in T cells at nanomolar concentrations","volume":"18","author":"Kim","year":"2018","journal-title":"Immune Netw"},{"key":"2023072808460591800_btad432-B24","author":"Kokhlikyan","year":"2020"},{"key":"2023072808460591800_btad432-B25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"key":"2023072808460591800_btad432-B26","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1158\/1078-0432.CCR-14-3281","article-title":"Phase II study of the AKT inhibitor MK-2206 plus erlotinib in patients with advanced non-small cell lung cancer who previously progressed on erlotinib","volume":"21","author":"Lara","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2023072808460591800_btad432-B27","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1016\/S0021-9258(18)82154-8","article-title":"Inhibition of bradykinin- and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors","volume":"268","author":"Lee","year":"1993","journal-title":"J Biol Chem"},{"key":"2023072808460591800_btad432-B28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41418-020-00604-y","article-title":"Phosphorylation by Aurora b kinase regulates caspase-2 activity and function","volume":"28","author":"Lim","year":"2021","journal-title":"Cell Death Differ"},{"key":"2023072808460591800_btad432-B29","first-page":"2980","author":"Lin"},{"key":"2023072808460591800_btad432-B30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12859-019-2910-6","article-title":"Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Bioinform"},{"key":"2023072808460591800_btad432-B31","doi-asserted-by":"crossref","first-page":"22811","DOI":"10.1038\/srep22811","article-title":"A systematic study on drug-response associated genes using baseline gene expressions of the cancer cell line encyclopedia","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2023072808460591800_btad432-B32","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"2023072808460591800_btad432-B33","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Menden","year":"2019","journal-title":"Nat Commun"},{"key":"2023072808460591800_btad432-B34","author":"Morcos"},{"key":"2023072808460591800_btad432-B35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15384047.2015.1108485","article-title":"Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer","volume":"17","author":"Nakajima","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"2023072808460591800_btad432-B36","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2023072808460591800_btad432-B37","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"2023072808460591800_btad432-B38","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/bioinformatics\/btz158","article-title":"Dr.VAE: improving drug response prediction via modeling of drug perturbation effects","volume":"35","author":"Ramp\u00e1\u0161ek","year":"2019","journal-title":"Bioinformatics"},{"key":"2023072808460591800_btad432-B39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41420-021-00423-1","article-title":"Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models","volume":"7","author":"Riess","year":"2021","journal-title":"Cell Death Discov"},{"key":"2023072808460591800_btad432-B40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"2023072808460591800_btad432-B41","doi-asserted-by":"crossref","first-page":"bbac605","DOI":"10.1093\/bib\/bbac605","article-title":"A systematic assessment of deep learning methods for drug response prediction: from in vitro to clinical applications","volume":"24","author":"Shen","year":"2023","journal-title":"Brief Bioinform"},{"key":"2023072808460591800_btad432-B42","first-page":"3145","author":"Shrikumar"},{"key":"2023072808460591800_btad432-B43","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ygeno.2018.07.002","article-title":"Drug response prediction by ensemble learning and drug-induced gene expression signatures","volume":"111","author":"Tan","year":"2019","journal-title":"Genomics"},{"key":"2023072808460591800_btad432-B44","doi-asserted-by":"crossref","first-page":"111223","DOI":"10.1016\/j.biopha.2021.111223","article-title":"Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells","volume":"136","author":"Wu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2023072808460591800_btad432-B45","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2023072808460591800_btad432-B46","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btad432\/50854435\/btad432.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/39\/7\/btad432\/50982296\/btad432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/39\/7\/btad432\/50982296\/btad432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T04:48:01Z","timestamp":1690519681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btad432\/7222627"}},"subtitle":[],"editor":[{"given":"Peter","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btad432","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.07.535998","asserted-by":"object"}]},"ISSN":["1367-4811"],"issn-type":[{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,7,1]]},"article-number":"btad432"}}